117 related articles for article (PubMed ID: 3816106)
1. Effect of phenytoin on serum disopyramide concentrations.
Nightingale J; Nappi JM
Clin Pharm; 1987 Jan; 6(1):46-50. PubMed ID: 3816106
[TBL] [Abstract][Full Text] [Related]
2. Itraconazole and hydroxyitraconazole serum concentrations are reduced more than tenfold by phenytoin.
Ducharme MP; Slaughter RL; Warbasse LH; Chandrasekar PH; Van de Velde V; Mannens G; Edwards DJ
Clin Pharmacol Ther; 1995 Dec; 58(6):617-24. PubMed ID: 8529326
[TBL] [Abstract][Full Text] [Related]
3. Disopyramide: clinical indications, pharmacokinetics and laboratory assessment.
Taylor EH; Pappas AA
Ann Clin Lab Sci; 1986; 16(4):289-95. PubMed ID: 2427003
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability of phenytoin sodium capsules available in Thailand. Part II: In vivo study.
Suthisisang C; Payakachat N; Chulavatnatol S; Towanabut S
J Med Assoc Thai; 1998 Jan; 81(1):64-70. PubMed ID: 9470324
[TBL] [Abstract][Full Text] [Related]
6. Oral absorption kinetics of levetiracetam: the effect of mixing with food or enteral nutrition formulas.
Fay MA; Sheth RD; Gidal BE
Clin Ther; 2005 May; 27(5):594-8. PubMed ID: 15978308
[TBL] [Abstract][Full Text] [Related]
7. Concentration-dependence of disopyramide binding to plasma protein and its influence on kinetics and dynamics.
Lima JJ; Boudoulas H; Blanford M
J Pharmacol Exp Ther; 1981 Dec; 219(3):741-7. PubMed ID: 7299695
[TBL] [Abstract][Full Text] [Related]
8. Concomitant use of mirtazapine and phenytoin: a drug-drug interaction study in healthy male subjects.
Spaans E; van den Heuvel MW; Schnabel PG; Peeters PA; Chin-Kon-Sung UG; Colbers EP; Sitsen JM
Eur J Clin Pharmacol; 2002 Sep; 58(6):423-9. PubMed ID: 12242602
[TBL] [Abstract][Full Text] [Related]
9. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
Mahgoub AA; El-Medany AH; Abdulatif AS
Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
[TBL] [Abstract][Full Text] [Related]
10. Rapid infusion of phenytoin sodium loading doses.
Salem RB; Wilder BJ; Yost RL; Doering PL; Lee C
Am J Hosp Pharm; 1981 Mar; 38(3):354-7. PubMed ID: 7223748
[TBL] [Abstract][Full Text] [Related]
11. Absorption characteristics of three phenytoin sodium products after administration of oral loading doses.
Goff DA; Spunt AL; Jung D; Bellur SN; Fischer JH
Clin Pharm; 1984; 3(6):634-8. PubMed ID: 6509876
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid and blood concentrations of toltrazuril 5% suspension in the horse after oral dosing.
Furr M; Kennedy T
Vet Ther; 2000; 1(2):125-32. PubMed ID: 19757559
[TBL] [Abstract][Full Text] [Related]
13. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
14. Disposition of phenytoin in critically ill trauma patients.
Boucher BA; Rodman JH; Fabian TC; Cupit GC; Ludden TM; West ME; Ray MW
Clin Pharm; 1987 Nov; 6(11):881-7. PubMed ID: 3677565
[TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetics of disopyramide in patients with acute myocardial infarction.
Jounela AJ; Pentikäinen PJ; Oksanen K
Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):276-82. PubMed ID: 7107076
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
17. Intravenous disopyramide in acute myocardial infarction: a haemodynamic and pharmacokinetic study.
Cameron J; Stafford W; Pritchard D; Norris R; Ravenscroft P
J Cardiovasc Pharmacol; 1984; 6(1):126-31. PubMed ID: 6199595
[TBL] [Abstract][Full Text] [Related]
18. Relationship between the therapeutic effects or side-effects and the serum disopyramide or mono-N-dealkylated disopyramide concentration after repeated oral administration of disopyramide to arrhythmic patients.
Masuhara K; Ohno T; Hamaguchi K; Katoh K; Kashiwada K; Takahashi S; Tanaka Y; Someya K; Ogata H
Int J Clin Pharmacol Res; 1995; 15(3):103-13. PubMed ID: 8847151
[TBL] [Abstract][Full Text] [Related]
19. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic interaction of single doses of quinine and carbamazepine, phenobarbitone and phenytoin in healthy volunteers.
Amabeoku GJ; Chikuni O; Akino C; Mutetwa S
East Afr Med J; 1993 Feb; 70(2):90-3. PubMed ID: 8513749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
